Daniel Eduardo Carvajal Hausdorf

Patólogo Staff

Clínica Alemana - Facultad de Medicina Universidad del Desarrollo

Santiago, Chile

Líneas de Investigación

Biomarcadores moleculares. Cáncer de mama. Cáncer de pulmón. Cáncer de vesícula biliar. Análisis de imágenes. Métodos objetivos de análisis.


  •  Médico-Cirujano, UNIVERSIDAD DE CHILE. Chile, 2008
  •  Médico Especialista en Anatomía Patológica, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2012

Experiencia Académica

  •   Postdoctoral Associate Full Time


    New Haven, CT, Chile

    2012 - 2017

  •   Profesor Investigador Asistente Adjunto Other


    Facultad de Medicina Clinica Alemana Universidad del Desarrollo

    Santiago, Chile

    2022 - A la fecha

Formación de Capital Humano

Doctoral Thesis: IL-11 and OSM promote tumor progression in TP53-mutated hormone receptor-positive breast cancer. Carla Araya, PhD (c), Doctorado en Ciencias e Innovación en Medicina, Facultad de Medicina Clinica Alemana Universidad del Desarrollo, Chile

Undergraduate Thesis: Clinical significance of the activation of signal transduction pathways in metastatic hormone receptor-positive breast cancer. Felipe Nahuelñir, School of Biochemistry, Universidad de Santiago, Chile.


Article (25)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
Immune Checkpoint Inhibitor-Associated Pericarditis
Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry
An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients
Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer
Laparoscopic management of incidental gallbladder cancer
Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer
Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer.
Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance.
Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.
Automated measurement of estrogen receptor in breast cancer=> a comparison of fluorescent and chromogenic methods of measurement.
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma.
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.
Objective measurement and clinical significance of TILs in non-small cell lung cancer.
Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.
In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.
Possible role of hemichannels in cancer.
Programmed death ligand-1 expression in non-small cell lung cancer.
[HER2 gene amplification and overexpression in advanced gastric cancer].
Breathing type and body position effects on sternocleidomastoid and suprahyoid EMG activity.
Evaluation of the impact of the COVID-19 pandemic in the diagnosis and treatment of breast cancer patients treated at Clínica Alemana de Santiago
Daniel Carvajal

Patólogo Staff

Laboratorio Clínico, Banco de Sangre y Anatomía Patológica

Clínica Alemana - Facultad de Medicina Universidad del Desarrollo

Santiago, Chile

Franz Villarroel

Jefe Laboratorio - PI

Departamento de Investigación del Cáncer

Fundación Arturo López Pérez

Santiago, Chile